Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2018
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer
T Aparicio, O Bouché, E Francois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2018
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T Aparicio, O Bouché, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2015
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02)
T Aparicio, S Lavau-Denes, J M Phelip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
D Azria, J Doyen, M Jarlier, et al.
Gastroenterologie Clinique Et Biologique
|
July 23, 1999
[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)]
J C Barbare, L Bedenne, O Bouché, et al.
Gastroenterologie Clinique Et Biologique
|
August 3, 1999
[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)]
J C Barbare, L Bedenne, O Bouché, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2018
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer
T Aparicio, O Bouché, E Francois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2018
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T Aparicio, O Bouché, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2015
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02)
T Aparicio, S Lavau-Denes, J M Phelip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
D Azria, J Doyen, M Jarlier, et al.
Gastroenterologie Clinique Et Biologique
|
July 23, 1999
[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)]
J C Barbare, L Bedenne, O Bouché, et al.
Gastroenterologie Clinique Et Biologique
|
August 3, 1999
[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)]
J C Barbare, L Bedenne, O Bouché, et al.
Page
of 9